No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
San Diego Biotech Jobs

Scientist / Associate Scientist, NK Cell Cancer Immunotherapy – Fate Therapeutics – San Diego, CA

(Scientist level) in immunology, cell biology, or a related field, and 2+ years of laboratory experience in an academic, biotechnology, or pharmaceutical… $24 an hourFrom Indeed – Fri, 03 Apr 2020 17:20:18 GMT – View all San Diego, CA jobs […]

No Picture
News

SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS

SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics co… […]